{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T02:57:14Z","timestamp":1781665034996,"version":"3.54.5"},"reference-count":14,"publisher":"Norwegian Medical Association","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"published-print":{"date-parts":[[2011,3,18]]},"DOI":"10.4045\/tidsskr.09.1499","type":"journal-article","created":{"date-parts":[[2011,3,21]],"date-time":"2011-03-21T08:43:17Z","timestamp":1300696997000},"page":"583-6","source":"Crossref","is-referenced-by-count":4,"title":["En ung kvinne som mistet kraften i ett bein"],"prefix":"10.4045","volume":"131","author":[{"given":"Trygve","family":"Holm\u00f8y","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8ivind","family":"Braaten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inger Anette Hyn\u00e5s","family":"Hovden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal M.","family":"Tallaksen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","reference":[{"key":"ref=1","unstructured":"Bindoff L, Gilhus NE. The genetic basis of muscle disease. Tidsskr Nor Laegeforen 2003; 123: 2588\u2009\u2013\u200992. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14714051&dopt=Abstract"},{"key":"ref=2","doi-asserted-by":"crossref","unstructured":"Seljeseth YM, Vollset SE, Tysnes OB. Increasing mortality from amyotrophic lateral sclerosis in Norway? Neurology 2000; 55: 1262\u2009\u2013\u20096. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11087765&dopt=Abstract","DOI":"10.1212\/WNL.55.9.1262"},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"Valdmanis PN, Daoud H, Dion PA et al. Recent advances in the genetics of amyotrophic lateral sclerosis. Curr Neurol Neurosci Rep 2009; 9: 198\u2009\u2013\u2009205. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19348708&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1007\/s11910-009-0030-9","DOI":"10.1007\/s11910-009-0030-9"},{"key":"ref=4","doi-asserted-by":"crossref","unstructured":"Mitchell JD, Borasio GD. Amyotrophic lateral sclerosis. Lancet 2007; 369: 2031\u2009\u2013\u200941. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17574095&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/S0140-6736(07)60944-1","DOI":"10.1016\/S0140-6736(07)60944-1"},{"key":"ref=5","doi-asserted-by":"crossref","unstructured":"Eisen A, Mezei MM, Stewart HG et al. SOD1 gene mutations in ALS patients from British Columbia, Canada: clinical features, neurophysiology and ethical issues in management. Amyotroph Lateral Scler 2008; 9: 108\u2009\u2013\u200919. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18428003&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1080\/17482960801900073","DOI":"10.1080\/17482960801900073"},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"Andersen PM, Sims KB, Xin WW et al. Sixteen novel mutations in the Cu\/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: a decade of discoveries, defects and disputes. Amyotroph Lateral Scler Other Motor Neuron Disord 2003; 4: 62\u2009\u2013\u200973. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14506936&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1080\/14660820310011700","DOI":"10.1080\/14660820310011700"},{"key":"ref=7","doi-asserted-by":"crossref","unstructured":"Holm\u00f8y T, Bj\u00f8rgo K, Roos PM. Slowly progressing amyotrophic lateral sclerosis caused by H46R SOD1 mutation. Eur Neurol 2007; 58: 57\u2009\u2013\u20098. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17483589&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1159\/000102170","DOI":"10.1159\/000102170"},{"key":"ref=8","doi-asserted-by":"crossref","unstructured":"Dion PA, Daoud H, Rouleau GA. Genetics of motor neuron disorders: new insights into pathogenic mechanisms. Nat Rev Genet 2009; 10: 769\u2009\u2013\u200982. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19823194&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1038\/nrg2680","DOI":"10.1038\/nrg2680"},{"key":"ref=9","doi-asserted-by":"crossref","unstructured":"Jonsson PA, Ernhill K, Andersen PM et al. Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis. Brain 2004; 127: 73\u2009\u2013\u200988. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14534160&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1093\/brain\/awh005","DOI":"10.1093\/brain\/awh005"},{"key":"ref=10","doi-asserted-by":"crossref","unstructured":"Andersen PM. Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene. Curr Neurol Neurosci Rep 2006; 6: 37\u2009\u2013\u200946. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16469270&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1007\/s11910-996-0008-9","DOI":"10.1007\/s11910-996-0008-9"},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"Jones CT, Swingler RJ, Simpson SA et al. Superoxide dismutase mutations in an unselected cohort of Scottish amyotrophic lateral sclerosis patients. J Med Genet 1995; 32: 290\u2009\u2013\u20092. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7643359&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1136\/jmg.32.4.290","DOI":"10.1136\/jmg.32.4.290"},{"key":"ref=12","doi-asserted-by":"crossref","unstructured":"Andersen PM, Borasio GD, Dengler R et al. Good practice in the management of amyotrophic lateral sclerosis: clinical guidelines. An evidence-based review with good practice points. Amyotroph Lateral Scler 2007; 8: 195\u2009\u2013\u2009213. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17653917&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1080\/17482960701262376","DOI":"10.1080\/17482960701262376"},{"key":"ref=13","doi-asserted-by":"crossref","unstructured":"Bensimon G, Lacomblez L, Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med 1994; 330: 585\u2009\u2013\u200991. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8302340&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1056\/NEJM199403033300901","DOI":"10.1056\/NEJM199403033300901"},{"key":"ref=14","doi-asserted-by":"crossref","unstructured":"Fanos JH, Gelinas DF, Miller RG. \u00abYou have shown me my end\u00bb: attitudes toward presymptomatic testing for familial amyotrophic lateral sclerosis. Am J Med Genet A 2004; 129A: 248\u2009\u2013\u200953. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15326623&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1002\/ajmg.a.30178","DOI":"10.1002\/ajmg.a.30178"}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":[],"language":"no","deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T02:38:40Z","timestamp":1781663920000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2011\/03\/noe-laere-av\/en-ung-kvinne-som-mistet-kraften-i-ett-bein"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,18]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,3,18]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.09.1499","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,18]]}}}